REDWOOD TOXICOLOGY LABORATORY

Oral Fluid Fentanyl Drug Testing

Fentanyl Drug Testing

Fentanyl and its analogs are extremely fast-acting synthetic narcotic analgesics, of high potency and short duration of action. These drugs have similar dependency properties to that of morphine.

Fentanyl use, originally for chronic pain, has increased in illicit street-use and among healthcare workers due to the drug's euphoric effects and wide availability.


Our oral fluid screen and confirmation service detects the presense of fentanyl, acetylfentanyl, acrylfentanyl, butyrylfentanyl, and furanyl- fentanyl. Screening is conducted via enzyme immunoassay (EIA) and confirmation analysis is performed via liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Features & Benefits

  • Laboratory analysis provides confirmative evidence of use
  • Detects therapeutic and illicitly synthesized forms of fentanyl, acetylfentanyl, acrylfentanyl, butyrylfentanyl, and furanylfentanyl
  • Useful in many situations: pain management, dependency/ rehabilitation, methadone clinics, and drug courts
  • Screened via EIA and confirmed on LC-MS/MS instrumentation
  • Toxicologists and support representatives available to assist you
  • Wide range of customizable reporting and data management solutions to fit your needs

Add oral fluid fentanyl testing to your drug screening program today.


To learn more about acetyl fentanyl and fentanyl testing call:

800.255.2159



References

1. Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014. Available at: https://www.cdc.gov/mmwr/volumes/65/wr/mm6533a2.htm?s_cid=mm6533a2_w
2. Drug Enforcement Administration - Fentanyl Overview. Available at: https://www.deadiversion.usdoj.gov/drug_chem_info/fentanyl.pdf
3. DEA Releases 2016 Drug Threat Assessment: Fentanyl-related overdose deaths rising at an alarming rate. Available at: https://www.dea.gov/press-releases/2016/12/06/dea-releases-2016-drug-threat-assessment-fentanyl-related-overdose-deaths
4. Testimony from Debra Houry, M.D. on Fentanyl: The Next Wave of the Opioid Crisis before Committee on Energy and Commerce. Available at: https://www.hhs.gov/about/agencies/asl/testimony/2017-03/fentanyl-next-wave-opioid-crisis.html?language=es

Contact Us

Laboratory: 800-255-2159

Products: 877-444-0049

Need help choosing a customized solution?

* required field(s)

Security Check CAPTCHA Image
Enter the characters as they are shown in the image above.

Ready to talk now?
Contact our Sales Team today. 800.255.2159